A Form 4 filed with the SEC on August 20, 2026, discloses that Eric Stanton Weiss, a director of Core Scientific, Inc./tx (NASDAQ:CORZ), purchased 7,000 shares of common stock on August 18, 2026.

Key Highlights

  • Reporting person: Eric Stanton Weiss, identified as a Director of Core Scientific, Inc./tx
  • Transaction: Purchase (transaction code P) of 7,000 shares of common stock on August 18, 2026
  • Weighted average price: $19.194 per share, with individual transactions ranging from $18.785 to $19.595, inclusive
  • Resulting ownership: 259,262 shares of common stock held directly following the transaction
  • Filing date: August 20, 2026, signed by Todd DuChene as Attorney-in-Fact

Director Purchase Details for Core Scientific Common Stock

According to the filing, Eric Stanton Weiss, a director at Core Scientific, Inc./tx, acquired 7,000 shares of the company's common stock on August 18, 2026. Core Scientific, Inc./tx trades on NASDAQ under the symbol CORZ. The shares were purchased across multiple transactions, and the filing reports a weighted average price of $19.194 per share.

The filing notes that the individual transaction prices ranged from $18.785 to $19.595, inclusive. The reporting person undertakes, according to the filing, "to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range." Following the reported purchase, Weiss directly held 259,262 shares of Core Scientific common stock, as disclosed in Table I of the Form 4.

No derivative securities transactions were reported in Table II of this filing. The Form 4 was filed by one reporting person and does not indicate that the transaction was made pursuant to a Rule 10b5-1 trading plan. The document was signed on August 20, 2026, by Todd DuChene acting as Attorney-in-Fact for Weiss.

What Was Disclosed

This Form 4 filing reports a direct open-market purchase of 7,000 shares of Core Scientific, Inc./tx common stock by director Eric Stanton Weiss on August 18, 2026, at a weighted average price of $19.194, resulting in direct beneficial ownership of 259,262 shares.